• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies News

Business

Regeneron and Fujifilm Forge $3B Biotech Alliance to Enhance US Pharmaceutical Production

Michael Lee 23 Apr, 2025

Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...

Popular News

  • Market

    Global Gold Prices Dip as Trade Tensions Ease and Investors Await Inflation Data

    15 May, 2025
  • Business

    Hong Kong Monetary Authority Slaps Indian Overseas Bank with Hefty Fine for AML Lapses

    23 Jul, 2025
  • Market

    European Markets Rally on Positive Economic Data and Anticipation for Inflation Reports

    15 Jan, 2025
  • Economy

    Italy's Inflation Holds Steady at 1.7% in July, Surpassing Analyst Expectations

    31 Jul, 2025
  • Business

    Defying US Sanctions: Indian Firm's Secret HMX Exports to Russia Fuel Military Tensions

    24 Jul, 2025
  • Business

    TSMC's $100 Billion Investment in US Chip Manufacturing: A Game-Changer for the Tech Industry

    04 Mar, 2025
  • Business

    Allianz and Jio Financial Services Forge Path for New Insurance Venture in India

    21 Mar, 2025
  • Business

    Top Stock Picks for January: DCX Systems Leads with a 46% Upside Potential

    03 Jan, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.